Literature DB >> 22710282

Dyslipidemia in granuloma annulare: a case-control study.

Wesley Wu1, Leslie Robinson-Bostom, Efi Kokkotou, Hye-Young Jung, George Kroumpouzos.   

Abstract

OBJECTIVES: To estimate the prevalence of dyslipidemia (DLP) among individuals with idiopathic granuloma annulare and to examine associations with disease characteristics and comorbidities, such as metabolic syndrome.
DESIGN: Case-control study using review of medical records from January 2002 through December 2010.
SETTING: A university hospital and a health care system. PARTICIPANTS: Adults consisting of 140 patients and 420 individuals serving as controls matched for age, sex, race/ethnicity, hypertension, type 2 diabetes mellitus, and hypothyroidism. MAIN OUTCOME MEASURES: Prevalence of DLP and its associated components (hypercholesterolemia, hypertriglyceridemia, elevated low-density lipoprotein cholesterol, and low high-density lipoprotein cholesterol) in idiopathic granuloma annulare, as well as odds ratio of DLP after adjusting for confounding variables.
RESULTS: The prevalence of DLP was 79.3% among granuloma annulare cases and 51.9% among controls (P.001). Granuloma annulare was associated with DLP (odds ratio, 4.04;95%CI,2.53-6.46) after adjusting for confounding variables. Statistically significant differences between patient and control groups were found for levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol (P.001 for all variables). A statistically significant association between the extent of disease and DLP (P=.02) was shown. Annular lesion morphology was associated with hypercholesterolemia (P=.02) and DLP (P=.01).
CONCLUSIONS: This study indicates an association between granuloma annulare and DLP. Dyslipidemia is more common in generalized than in localized/disseminated disease, and the annular lesion morphology is associated with hypercholesterolemia and DLP. Physicians should be aware of these important associations and consider them in the management of granuloma annulare.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710282     DOI: 10.1001/archdermatol.2012.1381

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  12 in total

1.  Case for diagnosis. Patch granuloma annulare.

Authors:  Geraldo Magela Magalhães; Cássio Ferreira Guimarães; Maysa Carla de Paula
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

2.  A Monocentric, Retrospective Analysis of 61 Patients with Generalized Granuloma Annulare.

Authors:  Thierry M Nordmann; Joo-Ri Kim; Reinhard Dummer; Florian Anzengruber
Journal:  Dermatology       Date:  2020-05-13       Impact factor: 5.366

Review 3.  Cutaneous Granulomatosis: a Comprehensive Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Carlo Mainetti; Marie-Astrid Peeters; Emmanuel Laffitte
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Localized Versus Generalized Granuloma Annulare: A Retrospective Review of 407 Patients.

Authors:  Ahmed Yousaf; Osama J Boustany; Michael Gerbo; Shanawar Waris; Stephen Davis; Wei Fang; Roxann Powers
Journal:  J Cutan Med Surg       Date:  2021-02-24       Impact factor: 2.854

Review 5.  Dyslipidemia in Dermatological Disorders.

Authors:  Chetana Shenoy; Manjunath Mala Shenoy; Gururaja K Rao
Journal:  N Am J Med Sci       Date:  2015-10

6.  Granuloma Annulare in the Setting of Secukinumab.

Authors:  Matthew L Clark; Courtney A Tobin; Angela Sutton; Tricia Ann Missall
Journal:  Case Rep Dermatol Med       Date:  2018-04-01

7.  Granuloma annulare: relationship to diabetes mellitus, thyroid disorders and tuberculin skin test.

Authors:  Pedram Alirezaei; Mahmood Farshchian
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-04-26

8.  Eruptive Xanthoma and Granuloma Annulare in Association with Metabolic Disorder.

Authors:  Rekha Virath; Sharad Mehta; Manisha Balai; Manju Meena; Lalit Kumar Gupta
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494

9.  Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms.

Authors:  John S Barbieri; Misha Rosenbach; Olaf Rodriguez; David J Margolis
Journal:  JAMA Dermatol       Date:  2021-07-01       Impact factor: 11.816

10.  Remission of generalized erythematous granuloma annulare after improvement of hyperlipidemia and review of the Japanese literature.

Authors:  Soko Watanabe; Masaru Tanaka; Ken Kobayashi; Mizuki Sawada; Sumiko Ishizaki; Koji Tsurui; Mariko Fujibayashi
Journal:  Dermatol Pract Concept       Date:  2014-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.